Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

NovaBridge Biosciences NBP NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
68/100
3/6 Pass
SharesGrow Intrinsic Value
$3.85
+48.1%
Analyst Price Target
$9.00
+246.2%

NovaBridge Biosciences (NBP) has 10 identified peers for comparison in the Healthcare sector. Peers include ALT, ANNX, AURA, DMAC, DRTS, DSGN and others.

NBP has a market capitalization of $299.69M, compared to an average peer market cap of $517.08M.

People Also View

LBRX
LBRX
LB Pharmaceuticals Inc Common Stock
$29.12
+9.60%
 DSGN
DSGN
Design Therapeutics, Inc.
$12.75
+0.87%
 ANNX
ANNX
Annexon, Inc.
$6.35
+9.48%
 DRTS
DRTS
Alpha Tau Medical Ltd.
$7.88
+0.64%
 AURA
AURA
Aura Biosciences, Inc.
$7.09
+0.07%
 RCKT
RCKT
Rocket Pharmaceuticals, Inc.
$3.88
+6.59%
 ENGN
ENGN
enGene Holdings Inc.
$7.76
+2.11%
 DMAC
DMAC
DiaMedica Therapeutics Inc.
$6.58
+0.61%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message